Please login to the form below

Not currently logged in
Email:
Password:

Proximagen

This page shows the latest Proximagen news and features for those working in and with pharma, biotech and healthcare.

UCB looks to pipeline with five years left for twin blockbusters

UCB looks to pipeline with five years left for twin blockbusters

Next in the pipeline is midazolam, a novel nasal spray for acute repetitive seizures in epilepsy which UCB acquired from Proximagen in June 2018 for an upfront fee of $150m, with

Latest news

  • BenevolentAI raises $115m to fund drug development BenevolentAI raises $115m to fund drug development

    BenevolentAI currently has 22 validated drug candidate programmes on the go, according to chief executive Ken Mulvany, formerly CEO of Proximagen, who describes the company as “a fully integrated, AI enabled

  • Artificial intelligence firm licenses Janssen candidates for development Artificial intelligence firm licenses Janssen candidates for development

    BenevolentAI was founded in 2013 as a spin-out of pharmaceutical company Proximagen.

  • Roche drops superbug partnership with Polyphor Roche drops superbug partnership with Polyphor

    But adds inflammation research agreement with Proximagen.  . Roche has opted to discontinue an alliance with Swiss biopharma company Polyphor to develop antibiotics for resistant infections. ... VAP-1 is a cell-adhesion molecule that may have a role to

  • High hopes

    Proximagen eyes AIM. Another university spin-out, Proximagen, is also planning to list on the stock market.

  • The waiting game

    Encouraging maiden interim results from Proximagen Neuroscience, a drug company specialising in neurodegenerative diseases, gave its depressed share price a useful lift.

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    sell to focus on its other companies Proximagen, an early-stage drug discovery and development company, and Pairnomix, a genetics research company.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics